Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis. [electronic resource]

By: Contributor(s): Producer: 20210405Description: 56 p. digitalISSN:
  • 1664-3224
Subject(s): Online resources: In: Frontiers in immunology vol. 11
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.